Elliott Investment Management’s push for change at Phillips 66 borrows straight from its successful playbook at Marathon Petroleum. In other words, it would probably be a mistake for Phillips 66…
Tag: SYND
He Plays the NFL’s Least Valued Position. He’s Never Been More Valuable.
By every shred of modern football thinking, San Francisco 49ers running back Christian McCaffrey should be a gigantic waste of a team’s budget. He’s the highest-paid player at a position…
Pressure Is Building in China’s Financial Plumbing
Plumbing is something most of us take for granted—until there’s a problem, at which point things can get messy fast. Likewise for the “plumbing” of modern financial systems: the money…
Remains of Crew From U.S. Military Aircraft Found in Japanese Waters
TOKYO—Searchers have found the sunken main fuselage of a U.S. military aircraft that crashed off the coast of southern Japan last week as well as the remains of five of…
Nvidia’s Rivals Prepare Their AI Assault
Nvidia was never going to have the artificial intelligence market all to itself. The past year has certainly made it seem that way, though. Nvidia’s sales have more than doubled—and…
Spotify to Lay Off 17% of Staff, Its Third Round of Job Cuts This Year
Updated Dec. 4, 2023 7:06 am ET Spotify is preparing to lay off 17% of its workforce or about 1,500 employees, as the company accelerates its profitability push. Chief Executive…
Binance Copped a $4 Billion Plea but Is Still Fighting the SEC
WASHINGTON—When top Biden administration officials gathered last month at the Justice Department to announce a $4.3 billion legal resolution with Binance, one powerful regulator was absent. Attorney General Merrick Garland…
CEOs Try to Beat Their Rivals in Softness and Cuddle-ability
Plush-toy makers play hardball in a competition for the squishiest creatures in the hot stuffed-animal market. Source link
Roche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 Bln
Roche aims to buy Carmot Therapeutics, a California-based pharmaceutical firm developing drugs to treat obesity and diabetes. The Swiss pharmaceutical company said it has entered an agreement to acquire the…